These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6517765)

  • 1. Intestinal antibodies in rats following exposure to live Vibrio cholerae.
    Cooper GN; McNab CE; Walker PG; Jackson GD
    Aust J Exp Biol Med Sci; 1984 Aug; 62 ( Pt 4)():465-77. PubMed ID: 6517765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin and specific-antibody synthesis in vitro by enteral and nonenteral lymphoid tissues after subcutaneous cholera immunization.
    Svennerholm AM; Holmgren J
    Infect Immun; 1977 Feb; 15(2):360-9. PubMed ID: 844901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
    Kabir S
    J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses of rats to live Vibrio cholerae: secretion of antibodies in bile.
    Jackson GD; Cooper GN
    Parasite Immunol; 1981; 3(2):127-35. PubMed ID: 7243338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunoassays for antibodies against Vibrio cholerae.
    Cooper GN; McNab CE; Jackson GD; Walker P
    Aust J Exp Biol Med Sci; 1983 Dec; 61 ( Pt 6)():713-25. PubMed ID: 6426450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans.
    Forrest BD; LaBrooy JT
    Vaccine; 1991 Jul; 9(7):515-20. PubMed ID: 1716810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in the intestinal fluid during convalescence.
    Chongsa-Nguan M; Chaicumpa W; Kalambaheti T; Surachedchai Y; Thanungkul B
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):33-8. PubMed ID: 3660066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous antigen expression in Vibrio cholerae vector strains.
    Butterton JR; Beattie DT; Gardel CL; Carroll PA; Hyman T; Killeen KP; Mekalanos JJ; Calderwood SB
    Infect Immun; 1995 Jul; 63(7):2689-96. PubMed ID: 7790086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae.
    Nygren E; Holmgren J; Attridge SR
    Vaccine; 2008 Dec; 26(52):6784-90. PubMed ID: 18951939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The secretory antibody response in milk and bile against fimbriae and LPS in rats monocolonized or immunized in the Peyer's patches with Escherichia coli.
    Dahlgren UI; Wold AE; Hanson LA; Midtvedt T
    Immunology; 1990 Oct; 71(2):295-300. PubMed ID: 1977693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization in adult mice to live and heat-killed Vibrio cholerae.
    Fujisawa H; Tsuru S; Taniguchi M; Zinnaka Y
    Microbiol Immunol; 1987; 31(8):763-70. PubMed ID: 3683219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and immunogenicity of a bivalent cell-surface protein-polysaccharide conjugate of Vibrio cholerae.
    Kabir S
    J Med Microbiol; 1987 Feb; 23(1):9-18. PubMed ID: 3820275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1982 Oct; 38(1):21-6. PubMed ID: 7141690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies (IgG) to lipopolysaccharide of Vibrio cholerae O1 mediate protection through inhibition of intestinal adherence and colonisation in a mouse model.
    Mukhopadhyay S; Nandi B; Ghose AC
    FEMS Microbiol Lett; 2000 Apr; 185(1):29-35. PubMed ID: 10731603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera toxin neutralization: a comparison of purified serum IgG and biliary secretory IgA antibodies.
    Pierre P; Langendries A; Vaerman JP
    Immunol Lett; 1988 May; 18(1):51-5. PubMed ID: 3378829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody synthesis in the rat liver: a source of biliary IgM, IgA and IgG following injection of horse erythrocytes into the intestine or Peyer's patches.
    Carter L; Jackson GD
    Adv Exp Med Biol; 1987; 216B():1147-56. PubMed ID: 3425423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vibriolytic IgG immunocyte response of mice after primary and secondary immunization with cholera somatic antigens.
    Friedman H
    Immunology; 1975 Aug; 29(2):283-99. PubMed ID: 51000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels and different repertoire profile of colostral anti-LPS antibodies may have a significant role in compensating newborn immunity.
    Nagao AT; Friedlander-Del Nero D; Arslanian C; Carneiro-Sampaio MM
    Scand J Immunol; 2001 Jun; 53(6):602-9. PubMed ID: 11422909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.